WPI 2233 Pill - white round, 10mm
Pill with imprint WPI 2233 is White, Round and has been identified as Tamoxifen Citrate 20 mg. It is supplied by Watson Pharmaceuticals, Inc.
Tamoxifen is used in the treatment of Breast Cancer; Breast Cancer, Male; Breast Cancer, Metastatic; Breast Cancer, Adjuvant; Breast Cancer, Palliative and belongs to the drug classes hormones/antineoplastics, selective estrogen receptor modulators. There is positive evidence of human fetal risk during pregnancy. Tamoxifen 20 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for WPI 2233
Tamoxifen Citrate
- Imprint
- WPI 2233
- Strength
- 20 mg
- Color
- White
- Size
- 10.00 mm
- Shape
- Round
- Availability
- Prescription only
- Drug Class
- Hormones/antineoplastics, Selective estrogen receptor modulators
- Pregnancy Category
- D - Positive evidence of risk
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Watson Pharmaceuticals, Inc.
- National Drug Code (NDC)
- 00591-2233 (Discontinued)
- Inactive Ingredients
-
croscarmellose sodium,
lactose monohydrate,
magnesium stearate,
microcrystalline cellulose,
corn starch
Note: Inactive ingredients may vary.
More about tamoxifen
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (97)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- Support group
- Drug class: hormones/antineoplastics
- Breastfeeding
- En español
Patient resources
Other brands
Professional resources
Other brands
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
